Logo image of IPGP

IPG PHOTONICS CORP (IPGP) Stock Fundamental Analysis

NASDAQ:IPGP - Nasdaq - US44980X1090 - Common Stock - Currency: USD

76.66  -2.21 (-2.8%)

Fundamental Rating

4

IPGP gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 124 industry peers in the Electronic Equipment, Instruments & Components industry. No worries on liquidiy or solvency for IPGP as it has an excellent financial health rating, but there are worries on the profitability. IPGP does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

IPGP had positive earnings in the past year.
IPGP had a positive operating cash flow in the past year.
Of the past 5 years IPGP 4 years were profitable.
Each year in the past 5 years IPGP had a positive operating cash flow.
IPGP Yearly Net Income VS EBIT VS OCF VS FCFIPGP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

1.2 Ratios

With a Return On Assets value of -9.05%, IPGP is not doing good in the industry: 62.90% of the companies in the same industry are doing better.
The Return On Equity of IPGP (-10.24%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -9.05%
ROE -10.24%
ROIC N/A
ROA(3y)1.4%
ROA(5y)3.68%
ROE(3y)1.57%
ROE(5y)4.2%
ROIC(3y)N/A
ROIC(5y)N/A
IPGP Yearly ROA, ROE, ROICIPGP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 15 20

1.3 Margins

In the last couple of years the Operating Margin of IPGP has declined.
IPGP's Gross Margin of 34.65% is in line compared to the rest of the industry. IPGP outperforms 56.45% of its industry peers.
IPGP's Gross Margin has declined in the last couple of years.
IPGP does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 34.65%
OM growth 3Y-60.56%
OM growth 5Y-41.77%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.12%
GM growth 5Y-5.58%
IPGP Yearly Profit, Operating, Gross MarginsIPGP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

9

2. Health

2.1 Basic Checks

IPGP does not have a ROIC to compare to the WACC, probably because it is not profitable.
IPGP has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, IPGP has less shares outstanding
There is no outstanding debt for IPGP. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
IPGP Yearly Shares OutstandingIPGP Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
IPGP Yearly Total Debt VS Total AssetsIPGP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

An Altman-Z score of 9.89 indicates that IPGP is not in any danger for bankruptcy at the moment.
IPGP's Altman-Z score of 9.89 is amongst the best of the industry. IPGP outperforms 87.90% of its industry peers.
There is no outstanding debt for IPGP. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 9.89
ROIC/WACCN/A
WACC9.47%
IPGP Yearly LT Debt VS Equity VS FCFIPGP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

A Current Ratio of 6.79 indicates that IPGP has no problem at all paying its short term obligations.
The Current ratio of IPGP (6.79) is better than 86.29% of its industry peers.
A Quick Ratio of 5.39 indicates that IPGP has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 5.39, IPGP belongs to the top of the industry, outperforming 86.29% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 6.79
Quick Ratio 5.39
IPGP Yearly Current Assets VS Current LiabilitesIPGP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

3

3. Growth

3.1 Past

IPGP shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -76.16%.
Measured over the past years, IPGP shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -19.50% on average per year.
The Revenue for IPGP has decreased by -14.77% in the past year. This is quite bad
Measured over the past years, IPGP shows a decrease in Revenue. The Revenue has been decreasing by -5.76% on average per year.
EPS 1Y (TTM)-76.16%
EPS 3Y-34.65%
EPS 5Y-19.5%
EPS Q2Q%-64.44%
Revenue 1Y (TTM)-14.77%
Revenue growth 3Y-12.55%
Revenue growth 5Y-5.76%
Sales Q2Q%-2.69%

3.2 Future

The Earnings Per Share is expected to grow by 20.68% on average over the next years. This is a very strong growth
Based on estimates for the next years, IPGP will show a small growth in Revenue. The Revenue will grow by 7.17% on average per year.
EPS Next Y-33.16%
EPS Next 2Y6.95%
EPS Next 3Y20.68%
EPS Next 5YN/A
Revenue Next Year-3.52%
Revenue Next 2Y1.92%
Revenue Next 3Y3.33%
Revenue Next 5Y7.17%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
IPGP Yearly Revenue VS EstimatesIPGP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 500M 1B
IPGP Yearly EPS VS EstimatesIPGP Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2 4 6

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 106.47, which means the current valuation is very expensive for IPGP.
IPGP's Price/Earnings ratio is in line with the industry average.
The average S&P500 Price/Earnings ratio is at 26.82. IPGP is valued rather expensively when compared to this.
Based on the Price/Forward Earnings ratio of 46.54, the valuation of IPGP can be described as expensive.
IPGP's Price/Forward Earnings is on the same level as the industry average.
IPGP is valuated rather expensively when we compare the Price/Forward Earnings ratio to 35.24, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 106.47
Fwd PE 46.54
IPGP Price Earnings VS Forward Price EarningsIPGP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of IPGP is on the same level as its industry peers.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of IPGP is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 50.44
EV/EBITDA 35.18
IPGP Per share dataIPGP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

IPGP's earnings are expected to grow with 20.68% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y6.95%
EPS Next 3Y20.68%

0

5. Dividend

5.1 Amount

No dividends for IPGP!.
Industry RankSector Rank
Dividend Yield N/A

IPG PHOTONICS CORP

NASDAQ:IPGP (8/19/2025, 2:05:52 PM)

76.66

-2.21 (-2.8%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)08-05 2025-08-05/bmo
Earnings (Next)10-27 2025-10-27/bmo
Inst Owners66.29%
Inst Owner Change7.85%
Ins Owners6.36%
Ins Owner Change-0.55%
Market Cap3.26B
Analysts54.67
Price Target69.36 (-9.52%)
Short Float %9.54%
Short Ratio10.42
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)6.22%
Min EPS beat(2)-57.53%
Max EPS beat(2)69.97%
EPS beat(4)2
Avg EPS beat(4)11.01%
Min EPS beat(4)-57.53%
Max EPS beat(4)69.97%
EPS beat(8)4
Avg EPS beat(8)5.09%
EPS beat(12)8
Avg EPS beat(12)8.18%
EPS beat(16)10
Avg EPS beat(16)8.23%
Revenue beat(2)1
Avg Revenue beat(2)2.7%
Min Revenue beat(2)-1.67%
Max Revenue beat(2)7.06%
Revenue beat(4)3
Avg Revenue beat(4)1.68%
Min Revenue beat(4)-1.67%
Max Revenue beat(4)7.06%
Revenue beat(8)4
Avg Revenue beat(8)-0.25%
Revenue beat(12)6
Avg Revenue beat(12)-0.61%
Revenue beat(16)9
Avg Revenue beat(16)0.1%
PT rev (1m)2.41%
PT rev (3m)-4%
EPS NQ rev (1m)-22.96%
EPS NQ rev (3m)-63.6%
EPS NY rev (1m)0%
EPS NY rev (3m)46.3%
Revenue NQ rev (1m)0.82%
Revenue NQ rev (3m)-3.91%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.83%
Valuation
Industry RankSector Rank
PE 106.47
Fwd PE 46.54
P/S 3.45
P/FCF 50.44
P/OCF 21.58
P/B 1.55
P/tB 1.65
EV/EBITDA 35.18
EPS(TTM)0.72
EY0.94%
EPS(NY)1.65
Fwd EY2.15%
FCF(TTM)1.52
FCFY1.98%
OCF(TTM)3.55
OCFY4.63%
SpS22.24
BVpS49.48
TBVpS46.51
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.05%
ROE -10.24%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 34.65%
FCFM 6.83%
ROA(3y)1.4%
ROA(5y)3.68%
ROE(3y)1.57%
ROE(5y)4.2%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)6.46%
ROCE(5y)8.05%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-60.56%
OM growth 5Y-41.77%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.12%
GM growth 5Y-5.58%
F-Score4
Asset Turnover0.4
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 141.45%
Cap/Sales 9.14%
Interest Coverage N/A
Cash Conversion 277.64%
Profit Quality N/A
Current Ratio 6.79
Quick Ratio 5.39
Altman-Z 9.89
F-Score4
WACC9.47%
ROIC/WACCN/A
Cap/Depr(3y)146.85%
Cap/Depr(5y)132.22%
Cap/Sales(3y)8.79%
Cap/Sales(5y)8.42%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-76.16%
EPS 3Y-34.65%
EPS 5Y-19.5%
EPS Q2Q%-64.44%
EPS Next Y-33.16%
EPS Next 2Y6.95%
EPS Next 3Y20.68%
EPS Next 5YN/A
Revenue 1Y (TTM)-14.77%
Revenue growth 3Y-12.55%
Revenue growth 5Y-5.76%
Sales Q2Q%-2.69%
Revenue Next Year-3.52%
Revenue Next 2Y1.92%
Revenue Next 3Y3.33%
Revenue Next 5Y7.17%
EBIT growth 1Y-105.93%
EBIT growth 3Y-65.51%
EBIT growth 5Y-45.12%
EBIT Next Year160.11%
EBIT Next 3Y40.32%
EBIT Next 5Y28.3%
FCF growth 1Y-42.28%
FCF growth 3Y-17.56%
FCF growth 5Y-4.7%
OCF growth 1Y-31.73%
OCF growth 3Y-14%
OCF growth 5Y-5.18%